Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAGR.L Regulatory News (BAGR)

  • There is currently no data for BAGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

27 Mar 2015 07:00

RNS Number : 6344I
Bagir Group Ltd
27 March 2015
 

27 March 2015

 

Bagir Group Ltd.

("Bagir" or the "Company")

 

Final Results

for the year ended 31 December 2014

 

Bagir (AIM: BAGR), a designer, creator and provider of innovative formalwear tailoring, announces its results for the year ended 31 December 2014.

 

Financial highlights

 

· Revenue of $97.0m (2013: $99.5m)

· Gross margin of 17.4% (2013: 18.8%)

· Operating income of $0.5m (2013: $3.6m)

· Adjusted operating income of $3.4m* (2013: $5.6m)

· Profit (loss) before tax of $(3.2)m (2013: $(1.2)m)

· Adjusted profit (loss) before tax of $(0.3)m* (2013: $0.9m)

· Adjusted EBITDA of $3.8m** (2013: $6.1m)

· Basic and fully diluted earnings (loss) per share of $(0.09)*** (2013: $(0.39))

· Net debt at 31 December 2014 of $12.5m (31 December 2013: $50.3m)

· Cash and cash equivalents at 31 December 2014 of $11.4m (31 Dec. 2013: $2.7m)

 

 

* Adjusted for amortization of intangible assets of $2.4m, IPO expenses of $0.3m and non-recurring recovery plan consultancy costs of $0.2m (PBT including finance expenses on pre IPO debt)

** Adjusted for depreciation of $0.4m, amortization of $2.4m, IPO expenses and non-recurring recovery plan consultancy costs

*** Including finance expenses on pre IPO debt

 

Operational highlights

 

· Admission to trading on AIM in April 2014, raising approximately $29.7m after expenses

· Successfully grew revenues from new and other existing retail customers by approximately 30% (excluding work wear) to help compensate for the substantial loss of revenues from the Company's largest customer due to a change in that customer's buying strategy

· Acquisition of a 50% stake in Nazareth Garments Share Company ("Nazareth") in Ethiopia, for the manufacturing of garments for global sales

· Comprehensive review of the Company's business strategy and operating processes and commencement of a two year recovery plan

· Financial covenants have been reset with the Company's banks for the years 2015 and 2016, in line with the Company's updated financial projections

 

 

Danny Taragan, CEO of Bagir Group Ltd, said:

"2014 was a transformational year for Bagir with our successful IPO on AIM in April. However, the Company did suffer some headwinds during the period but, despite the reduction in sales from our largest customer, management expects to continue to grow revenues from other existing and new customers in the UK and in the US.

 

"The comprehensive review into the Company's business strategy and operating processes was successfully completed and a two year recovery plan has commenced. Once fully implemented, the recovery plan is expected to reduce the Company's operating costs, improve efficiency and enhance the Company's sales and marketing performance.

 

"The acquisition of Nazareth in November 2014 was an exciting development in Bagir's journey and this production facility in Ethiopia is expected to give Bagir a strong competitive advantage once the planned upgrades have been implemented. The Board thanks shareholders for their continued support and looks to the future with confidence."

 

 

 

For further information, please contact:

 

Bagir Group Ltd.

Danny Taragan, Chief Executive Officer

Udi Cohen, Chief Financial Officer

 

via FTI Consulting

N+1 Singer

Jonny Franklin-Adams

Alex Wright

 

+44 (0) 20 7496 3000

FTI Consulting

Alex Beagley / Tom Hufton

+44 (0) 20 3727 1000

 

 

 

Strategic and Financial Review

 

In April 2014, Bagir completed a successful admission to trading on the AIM Market of the London Stock Exchange, raising approximately £20.0 million (US$33.5 million) before expenses through the placing of 35,714,285 new shares. IPO related costs amounted to approximately $3.8 million.

 

As announced in May 2014, the business lost a substantial proportion of its planned revenue due to a change in the buying strategy by its largest customer. The Company has however successfully grown revenue elsewhere by approximately 30% (excluding workwear) through additional sales to other existing and new retail customers.

 

In November 2014, the Company purchased a 50% stake in Nazareth Garments Share Company ("Nazareth"), an Ethiopian company which owns and operates a garment factory in Ethiopia. As this business and its facilities are developed as part of Bagir's investment, it is expected to give Bagir a strong competitive advantage due to its duty free exports to the EU and US, its competitive production costs and government's support for the textile industry.

 

In September 2014 the Company announced a comprehensive review of its business strategy and operating processes. This review has been completed and the Company has commenced a two year recovery plan. This plan is designed to increase the competitiveness of our business through both operational improvements and cost reductions.

 

The Company will continue to focus on growing its quality tailored menswear private label business through existing and new customers. In addition, the Company is planning to further develop its brand licensing activity, mainly in the US, on a royalty paid basis. As part of the recovery plan the Company's production and management processes will be restructured, with efficiency improvements supported by additional IT development. Once fully implemented, the plan is expected to achieve significant annual cost reductions.

 

The comprehensive two year recovery plan and the increased competitive advantage of the new factory in Ethiopia along with the organic growth with customers and additional private label sales, are expected to deliver improved results in future years and strengthen the position of the Company in its market place.

 

The Company's financial covenants have been reset by its banks for the years 2015 and 2016, in line with the Company's updated financial projections.

 

Revenue

Revenue for the year ended 31 December 2014 was $97.0m. This was a $2.5m reduction on the comparable period last year, which was due mainly to the reduction in sales to the Company's largest customer and a large project for a customer that was completed by the Company during 2013, which as expected, did not continue into 2014. This was partly offset by increased revenues with other customers in the UK and in the US during 2014.

 

Gross margin

The gross margin for the year ended 31 December 2014 was 17.4% compared with 18.8% for 2013. This decline was mainly due to the reduction in business from the Company's largest customer, the completion of the large project mentioned above which had relatively higher margins, negative currency impact of the devaluation of the pound\dollar exchange rate and the higher depreciation of amortized intangible assets ($1.6m in 2014 compared to $1.1m in 2013).

 

Operating expenses

The general and administrative expenses increased to $4.3m in the period (2013: $3.7m), due predominantly to the additional administrative costs associated with being a quoted company. In addition, $0.3m one-off costs were incurred associated with the Company's IPO. These costs have been included as part of the Company's operating expenses for the period.

 

The two year recovery plan being implemented by the Company is, once fully implemented, expected to reduce operating costs going forward.

 

Adjusted operating income and profit (loss) before taxation

Adjusted operating income and profit (loss) before tax (before $2.4m amortization of intangible assets (2013: $2.0m) and before $0.3m IPO expenses and $0.2m non-recurring recovery plan consultancy costs) for the year ended 31 December 2014 was $3.4m and $(0.3)m respectively, compared with $5.6m and $0.9m respectively for 2013. The loss before tax was after finance expenses on pre-IPO debt.

 

Adjusted EBITDA

Adjusted EBITDA (before IPO expenses and non-recurring recovery plan consultancy costs) for the year ended 31 December 2014 was $3.8m (2013: $6.1m).

 

Loss per share

Basic and fully diluted earnings (loss) per share for the period was $(0.09) (2013: $0.39 loss).

 

Net debt

As at 31 December 2014, net debt decreased significantly to approximately $12.5m compared with $50.3m at 31 December 2013. Net debt reduced as a result of the Company's IPO in April 2014 and the conversion of the Company's capital notes to shareholders and loans from shareholders into equity.

 

Cash and cash equivalents

As at 31 December 2014, cash and cash equivalents increased to $11.4m compared with $2.7m at 31 December 2013, as a result of the IPO proceeds.

 

Outlook

Despite the reduction in sales from the Company's largest customer, the Company expects to continue to grow the revenues from other existing and new customers in the UK and in the US.

 

Once fully implemented, the recovery plan is expected to reduce the Company's operating costs, improve efficiency and enhance the Company's sales and marketing performance.

 

In addition, the newly purchased production facility in Ethiopia is expected to give Bagir a strong competitive advantage once the planned upgrades have been implemented.

 

 

 

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

31 December

2014

2013

U.S. dollars in thousands

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

11,420

2,670

Short-term investments

397

600

Trade receivables

10,247

8,168

Other receivables

3,017

2,047

Inventories

10,379

6,620

35,460

20,105

NON-CURRENT ASSETS:

Investment in a joint venture

1,765

-

Bank deposits

-

290

Property, plant and equipment

1,308

1,595

Goodwill

5,689

5,689

Other intangible assets

4,968

7,234

Deferred taxes

372

486

14,102

15,294

49,562

35,399

 

 

 

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

31 December

2014

2013

U.S. dollars in thousands

LIABILITIES AND EQUITY

CURRENT LIABILITIES:

Credit from banks and current maturities of long-term loans

11,880

11,537

Trade payables

7,351

6,852

Other payables

5,597

9,773

24,828

28,162

NON-CURRENT LIABILITIES:

Loans from banks

12,025

20,700

Capital notes to shareholders and loans from shareholders and their related companies

-

20,748

Employee benefit liabilities

456

479

Obligation relating to lease agreement

155

793

Payable for acquisition of subsidiary

-

461

Deferred taxes

116

164

12,752

43,345

EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:

Share capital

574

30

Share premium

78,322

27,879

Capital reserve for share-based payment transactions

1,444

1,411

Capital reserve for transactions with shareholders

10,165

10,165

Adjustments arising from translation of foreign operations

(8,895)

(9,111)

Accumulated deficit

(71,574)

(68,428)

10,036

(38,054)

Non-controlling interests

1,946

1,946

Total equity (deficiency)

11,982

(36,108)

49,562

35,399

 

 

 

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND

OTHER COMPREHENSIVE INCOME

 

Year ended 31 December

2014

2013

U.S. dollars in thousands

Revenues from sales

96,982

99,490

Cost of sales

80,075

 (*80,749

Gross profit

16,907

18,741

Selling and marketing expenses

8,693

8,665

General and administrative expenses

4,321

3,682

Development costs

3,198

 (*3,079

Expenses in connection with IPO

301

-

Other income, net

121

289

Operating income

515

3,604

Finance income

6

427

Finance expenses

(3,164)

(3,531)

Finance expenses relating to liabilities to shareholders

(562)

(1,589)

Company's share of losses of a joint venture

(12)

(110)

Other income, net

-

19

Loss before taxes on income

(3,217)

(1,180)

Taxes on income (tax benefit)

(39)

40

Loss

(3,178)

(1,220)

Other comprehensive income (loss):

Items to be reclassified or that are reclassified to profit or loss when specific conditions are met:

 Adjustments arising from translation of foreign operations

216

(12)

Items not to be reclassified to profit or loss in subsequent periods:

Remeasurement gain on defined benefit plans

32

6

Total other comprehensive income (loss)

248

(6)

Total comprehensive loss

(2,930)

(1,226)

 Loss attributable to equity holders of the Company

(3,178)

(1,220)

 Total comprehensive loss attributable to equity holders of the Company

(2,930)

(1,226)

 

*) Reclassified.

 

 

 

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND

OTHER COMPREHENSIVE INCOME

 

Year ended 31 December

2014

2013

U.S. dollars

Loss per share attributable to equity holders of the Company (in dollars)

 Basic and diluted loss

(0.09)

(0.39)

Weighted average number of Ordinary shares for basic and diluted loss per share *) (in thousands)

36,486

3,125

*) After share split

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIENCY)

 

Attributable to equity holders of the Company

Share

capital

Share premium

Capital reserve for share-based payment transactions

Capital reserve for transactions with shareholders

Adjustments arising from translation of foreign operations

Accumulated deficit

Total

Non-controlling interests

Total equity (deficiency)

U.S. dollars in thousands

Balance at 1 January 2014

30

27,879

1,411

10,165

(9,111)

(68,428)

(38,054)

1,946

(36,108)

Loss

-

-

-

-

-

(3,178)

(3,178)

-

(3,178)

Other comprehensive income:

Adjustments arising from translation of foreign operations

-

-

-

-

216

-

216

-

216

Remeasurement gain on defined benefit plans

-

-

-

-

-

32

32

-

32

Total other comprehensive income

-

-

-

-

216

32

248

-

248

Total comprehensive income (loss)

-

-

-

-

216

(3,146)

(2,930)

-

(2,930)

Issue of share capital (net of issue expenses of $ 3.8 million)

412

29,265

-

-

-

-

29,677

-

29,677

Conversion of capital notes to shareholders and loans from shareholders into shares

132

21,178

-

-

-

-

21,310

-

21,310

Cost of share-based payment

-

-

33

-

-

-

33

-

33

Balance at 31 December 2014

574

78,322

1,444

10,165

(8,895)

(71,574)

10,036

1,946

11,982

 

 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIENCY)

 

 

Attributable to equity holders of the Company

Share

capital

Share premium

Capital reserve for share-based payment transactions

Capital reserve for transactions with shareholders

Adjustments arising from translation of foreign operations

Accumulated deficit

Total

Non-controlling interests

Total equity (deficiency)

U.S. dollars in thousands

Balance at 1 January 2013

30

27,879

 1,367

5,623

(9,099)

(67,214)

(41,414)

1,946

(39,468)

Loss

-

-

-

-

-

(1,220)

(1,220)

-

(1,220)

Other comprehensive loss:

Adjustments arising from translation of foreign operations

-

-

-

-

(12)

-

(12)

-

(12)

Remeasurement gain on defined benefit plans

-

-

-

-

-

6

6

-

6

Total other comprehensive loss

-

-

-

-

(12)

6

(6)

-

(6)

Total comprehensive loss

-

-

-

-

(12)

(1,214)

(1,226)

-

(1,226)

Cost of share-based payment

-

-

44

-

-

-

44

-

44

Capital reserve for capital notes to shareholders and loans from shareholders

-

-

-

4,542

-

-

4,542

-

4,542

Balance at 31 December 2013

30

27,879

1,411

10,165

(9,111)

(68,428)

(38,054)

1,946

(36,108)

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Year ended 31 December

2014

2013

U.S. dollars in thousands

Cash flows from operating activities:

Loss

(3,178)

(1,220)

Adjustments to reconcile loss to net cash provided by (used in) operating activities:

Company's share of losses of a joint venture

12

110

Depreciation and amortization

2,829

2,487

Deferred taxes, net

66

(48)

Change in employee benefit liabilities

9

(97)

Cost of share-based payment

33

44

Gain from sale of property, plant and equipment

-

(16)

Finance expenses, net

1,776

4,065

Tax expenses (income), net

(105)

88

Other

476

80

5,096

6,713

Changes in asset and liability items:

Decrease (increase) in trade receivables

(2,155)

288

Decrease (increase) in other receivables

(801)

1,090

Decrease (increase) in inventories

(3,827)

519

Increase (decrease) in trade payables

520

(1,307)

Decrease in other payables

(3,815)

(5,174)

(10,078)

(4,584)

Cash paid (received) during the year for:

Interest paid

(1,439)

(1,948)

Interest received

23

-

Taxes paid

(264)

(2)

(1,680)

(1,950)

Net cash used in operating activities

(9,840)

(1,041)

 

 

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Year ended 31 December

2014

2013

U.S. dollars in thousands

Cash flows from investing activities:

Investment in joint venture

(1,657)

-

Purchase of property, plant and equipment

(148)

(258)

Proceeds from sale of property, plant and equipment

-

16

Capitalisation of development costs

(150)

-

Realisation of short-term investments, net

203

11

Bank deposits, net

290

-

Proceeds from sale of assets held for sale

-

607

Proceeds from sale of investment in a joint venture

-

2,707

Dividend from a joint venture

-

442

Net cash provided by (used in) investing activities

(1,462)

3,525

Cash flows from financing activities:

Issue of shares, net of expenses

29,677

-

Receipt of loans from banks

3,000

23,000

Payment of loans from banks

(10,797)

(12,891)

Decrease in short-term credit, net

(530)

(12,244)

Repayment of liability for acquisition of subsidiary

(1,250)

(939)

Net cash provided by (used in) financing activities

20,100

(3,074)

Translation differences on balances of cash and cash equivalents of foreign operations

(48)

(15)

Increase (decrease) in cash and cash equivalents

8,750

(605)

Cash and cash equivalents at the beginning of the year

2,670

3,275

Balance of cash and cash equivalents at the end of the year

11,420

2,670

 

Non-cash transactions:

Conversion of capital notes to shareholders and loans from shareholders into shares

21,310

-

Payables for investment in joint venture

120

-

 

 

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

NOTE 1:- GENERAL

 

a. Company description:

 

Bagir Group Ltd. ("the Company") is registered in Israel. The Company and its subsidiaries ("the Group") specialise in the manufacturing and marketing of men's and women's tailored fashion. The Company's Headquarters are located in Kiryat Gat, Israel. The Group's products are manufactured by a subsidiary and subcontractors. The Group's products are marketed in Europe (mainly in the U.K.), the U.S. and in other countries.

 

b. In April 2014 the Company completed an initial public offering ("IPO") and its shares were admitted to trading on the London Stock Exchange's Alternative Investment Market (AIM). In the IPO, the Company issued 35,714,285 Ordinary shares at a price of 56 pence per Ordinary share. The total gross funds raised in the IPO were GBP 20 million ($33.5 million) and IPO related costs amounted to approximately $3.8 million.

 

Concurrent with the IPO, the Company issued 11,383,925 Ordinary shares to certain shareholders in consideration for the extinguishment of all capital notes and loans due to these shareholders with a carrying amount of approximately $21,310 thousand (par value of approximately $25,989 thousand).

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES

 

 

Assessment of going concern:

 

The Board has adopted the going concern basis of accounting in preparing the financial statements. In assessing the appropriateness of doing so the Board has considered the principal risks and uncertainties of the business, the trading forecasts covering a twelve months period following the approval of the financial statements (including downside sensitivities) and the debt facilities provided by the Company's banks and the covenants relating to those facilities. 

 

NOTE 3:- NET EARNINGS (LOSS) PER SHARE

 

Details of the number of shares and loss used in the computation of basic and diluted loss per share:

 

Year ended 31 December

2014

2013

Weighted number of shares (1)

Loss from operations

Weighted number of shares (1)

Loss from operations

In thousands

U.S. dollars in thousands

In thousands

U.S. dollars in thousands

(2) 36,486

(3,178)

3,125 (2)

(1,220)

 

(1) The data related to the computation of basic and diluted loss per share (options and warrants have not been included as they are antidilutive).

 

(2) The weighted number or shares are after share split.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR PGUUUWUPAPGQ
Date   Source Headline
18th May 20205:30 pmRNSBagir Group
18th May 202012:10 pmRNSAppointment of Liquidator
22nd Apr 20207:00 amRNSAppointment of Court Trustees
14th Apr 20207:00 amRNSFinancial Update
3rd Apr 20207:30 amRNSSuspension - Bagir Group Ltd
3rd Apr 20207:30 amRNSFinancial Update
31st Mar 20207:00 amRNSHolding(s) in Company
25th Mar 202012:00 pmRNSCOVID-19 Update
23rd Mar 20209:03 amRNSHolding(s) in Company
17th Mar 20201:24 pmRNSHolding(s) in Company
16th Mar 20208:20 amRNSHolding(s) in Company
2nd Mar 202011:20 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSUpdate on status with Shandong Ruyi and 19 Trading
13th Feb 20208:18 amRNSResignation of Chairperson
21st Jan 20207:55 amRNSHolding(s) in Company
13th Dec 20192:06 pmRNSHolding(s) in Company
2nd Dec 201911:02 amRNSResult of AGM
29th Nov 20198:20 amRNSHolding(s) in Company
22nd Oct 20199:46 amRNSNotice of AGM
7th Oct 20199:17 amRNSHolding(s) in Company
3rd Oct 20194:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20193:29 pmRNSHolding(s) in Company
2nd Oct 20193:20 pmRNSHolding(s) in Company
26th Sep 20197:00 amRNSHalf-year Report
10th Sep 201911:30 amRNSHolding(s) in Company
10th Sep 201910:55 amRNSHolding(s) in Company
5th Sep 201910:35 amRNSHolding(s) in Company
23rd Aug 20193:08 pmRNSHolding(s) in Company
19th Aug 20193:48 pmRNSHolding(s) in Company
12th Aug 20193:49 pmRNSHolding(s) in Company
12th Aug 20198:49 amRNSHolding(s) in Company
28th Jun 20197:00 amRNSPosting of Annual Report
25th Jun 20197:00 amRNSDirectorate Change
19th Jun 20197:00 amRNSUpdate on Strategic Partnership and Trading
31st May 201911:05 amRNSSecond Price Monitoring Extn
31st May 201911:00 amRNSPrice Monitoring Extension
31st May 20197:00 amRNSUpdate on Strategic Partnership
28th May 20192:05 pmRNSSecond Price Monitoring Extn
28th May 20192:00 pmRNSPrice Monitoring Extension
20th May 20194:40 pmRNSSecond Price Monitoring Extn
20th May 20194:35 pmRNSPrice Monitoring Extension
13th May 20197:00 amRNSDirectorate Change
4th Apr 20197:00 amRNSFinal Results
22nd Mar 201912:01 pmRNSHolding(s) in Company
15th Feb 201910:38 amRNSHolding(s) in Company
13th Feb 20192:00 pmRNSPrice Monitoring Extension
13th Feb 20197:00 amRNSUpdate on strategic partnership
3rd Jan 20192:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20192:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.